BIODESIX INC (BDSX) Stock Income Statement
NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 74.46M | 71.32M | 49.09M | 38.21M | 54.51M | |||
| Cost Of Goods | 16.10M | 15.57M | 13.01M | 14.15M | 30.52M | |||
| Gross Profit | 58.36M | 55.75M | 36.08M | 24.06M | 23.99M | |||
| Operating Expenses | 90.73M | 90.01M | 77.38M | 74.57M | 64.93M | |||
| Research and Development | 10.39M | 9.56M | 9.99M | 13.10M | 12.79M | |||
| Selling, General, and Administrative Expenses | 80.34M | 75.09M | 64.52M | 58.46M | 47.96M | |||
| Operating Income | -32.37M | -34.26M | -41.30M | -50.51M | -40.94M | |||
| Interest Income/Expense | -7.41M | -8.26M | -9.54M | -8.07M | -4.51M | |||
| Other Income/Expense | -143.00K | 73.00K | -1.27M | 190.00K | -10.00K | |||
| Non Recurring Items | -491.00K | -486.00K | -44.00K | -7.06M | 2.30M | |||
| Income Before Taxes | -40.42M | -42.93M | -52.15M | -65.45M | -43.16M | |||
| Net Income | -40.42M | -42.93M | -52.15M | -65.45M | -43.16M | |||
| EBITDA | -26.58M | -28.49M | -37.97M | -46.91M | -37.76M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.29 | -0.33 | -0.64 | -1.55 | -1.58 | |||
| Non GAAP EPS | -0.29 | -0.35 | -0.65 | -1.59 | -1.54 | |||
| Statistics | ||||||||
| Gross Profit Margin | 78.38% | 78.17% | 73.50% | 62.97% | 44.01% | |||
| Profit Margin | -54.28% | -60.19% | -106.23% | -171.29% | -79.18% | |||
| Operating Profit Margin | -43.47% | -48.03% | -84.13% | -132.19% | -75.11% | |||
All data in USD